Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Concomitant Temperature Stress and Immune Activation may Increase Mortality Despite Efficient Clearance of an Intracellular Bacterial Infection in Atlantic Cod.

Larsen AK, Nymo IH, Sørensen KK, Seppola M, Rødven R, Jiménez de Bagüés MP, Al Dahouk S, Godfroid J.

Front Microbiol. 2018 Dec 4;9:2963. doi: 10.3389/fmicb.2018.02963. eCollection 2018.

2.

Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment.

François S, Usunier B, Forgue-Lafitte ME, L'Homme B, Benderitter M, Douay L, Gorin NC, Larsen AK, Chapel A.

Stem Cells Transl Med. 2018 Nov 19. doi: 10.1002/sctm.18-0117. [Epub ahead of print]

3.

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study.

Fotiou D, Sergentanis TN, Papageorgiou L, Stamatelopoulos K, Gavriatopoulou M, Kastritis E, Psaltopoulou T, Salta S, Van Dreden P, Sangare R, Larsen AK, Terpos E, Elalamy I, Dimopoulos MA, Gerotziafas GT.

Blood Cancer J. 2018 Nov 7;8(11):102. doi: 10.1038/s41408-018-0135-y.

4.

Comparison of antithrombin-dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots.

Salta S, Papageorgiou L, Larsen AK, Van Dreden P, Soulier C, Cokkinos DV, Elalamy I, Gerotziafas GT.

Res Pract Thromb Haemost. 2018 Jul 17;2(4):696-707. doi: 10.1002/rth2.12120. eCollection 2018 Oct.

5.

Transient increase of CA 19-9 serum concentrations in a liver transplant recipient with cystic fibrosis and hepatic abscess: a case report and brief literature review.

Denis JA, Mazzola A, Nguyen G, Lacorte JM, Brochet C, Larsen AK, Conti F.

Clin Biochem. 2018 Oct 17. pii: S0009-9120(18)31035-X. doi: 10.1016/j.clinbiochem.2018.10.009. [Epub ahead of print]

PMID:
30342018
6.

FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer.

Carola C, Ghiringhelli F, Kim S, André T, Barlet J, Bengrine-Lefevre L, Marijon H, Garcia-Larnicol ML, Borg C, Dainese L, Steuer N, Richa H, Benetkiewicz M, Larsen AK, de Gramont A, Chibaudel B.

World J Clin Oncol. 2018 Sep 14;9(5):110-118. doi: 10.5306/wjco.v9.i5.110.

7.

[Classification of vascular anomalies].

Larsen AK, Damsgaard TE, Hedelund L.

Ugeskr Laeger. 2018 Sep 3;180(36). pii: V11170857. Danish.

PMID:
30187855
8.

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study.

Syrigos K, Grapsa D, Sangare R, Evmorfiadis I, Larsen AK, Van Dreden P, Boura P, Charpidou A, Kotteas E, Sergentanis TN, Elalamy I, Falanga A, Gerotziafas GT.

Oncologist. 2018 Nov;23(11):1372-1381. doi: 10.1634/theoncologist.2017-0530. Epub 2018 Aug 13.

PMID:
30104289
9.

Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status.

Mésange P, Bouygues A, Ferrand N, Sabbah M, Escargueil AE, Savina A, Chibaudel B, Tournigand C, André T, de Gramont A, Larsen AK.

Clin Cancer Res. 2018 Jun 1;24(11):2548-2558. doi: 10.1158/1078-0432.CCR-17-3187. Epub 2018 Feb 28.

PMID:
29490990
10.

Brucella Antibodies in Alaskan True Seals and Eared Seals-Two Different Stories.

Nymo IH, Rødven R, Beckmen K, Larsen AK, Tryland M, Quakenbush L, Godfroid J.

Front Vet Sci. 2018 Jan 31;5:8. doi: 10.3389/fvets.2018.00008. eCollection 2018.

11.

Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group.

Perego P, Hempel G, Linder S, Bradshaw TD, Larsen AK, Peters GJ, Phillips RM; EORTC PAMM Group.

Cancer Chemother Pharmacol. 2018 Mar;81(3):427-441. doi: 10.1007/s00280-017-3502-7. Epub 2017 Dec 28. Review.

PMID:
29285635
12.

The role of managers in addressing employees with musculoskeletal pain: a mixed methods study.

Larsen AK, Falkenstrøm S, Jørgensen MB, Rod MH.

Int Arch Occup Environ Health. 2018 Apr;91(3):361-372. doi: 10.1007/s00420-017-1284-1. Epub 2017 Dec 21.

13.

Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer.

Rousseau A, Van Dreden P, Khaterchi A, Larsen AK, Elalamy I, Gerotziafas GT.

Int J Oncol. 2017 Dec;51(6):1793-1800. doi: 10.3892/ijo.2017.4170. Epub 2017 Oct 20.

PMID:
29075792
14.

Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells.

Rousseau A, Larsen AK, Van Dreden P, Sabbah M, Elalamy I, Gerotziafas GT.

Int J Oncol. 2017 Dec;51(6):1747-1756. doi: 10.3892/ijo.2017.4172. Epub 2017 Oct 20.

PMID:
29075790
15.

Application of real-time quantitative PCR assays for detecting marine Brucella spp. in fish.

Norman SA, Delaney MA, Haman KH, Thomas AC, Godfroid J, Larsen AK, Nymo IH, Robbe-Austerman S, Quance C, Rhyan JC, Lambourn DM, Jeffries SJ, Rabinowitz P.

J Vet Diagn Invest. 2018 Jan;30(1):150-154. doi: 10.1177/1040638717733024. Epub 2017 Oct 6.

PMID:
28985698
16.

Graft Product for Autologous Peripheral Blood Stem Cell Transplantation Enhances Thrombin Generation and Expresses Procoagulant Microparticles and Tissue Factor.

Sidibe F, Spanoudaki A, Vanneaux V, Mbemba E, Larghero J, Van Dreden P, Lotz JP, Elalamy I, Larsen AK, Gerotziafas GT.

Clin Appl Thromb Hemost. 2018 May;24(4):684-690. doi: 10.1177/1076029617715116. Epub 2017 Jul 6.

PMID:
28681632
17.

The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing.

Denis JA, Guillerm E, Coulet F, Larsen AK, Lacorte JM.

Mol Diagn Ther. 2017 Dec;21(6):587-600. doi: 10.1007/s40291-017-0287-7. Review.

PMID:
28667577
18.

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.

Gerotziafas GT, Taher A, Abdel-Razeq H, AboElnazar E, Spyropoulos AC, El Shemmari S, Larsen AK, Elalamy I; COMPASS–CAT Working Group.

Oncologist. 2017 Oct;22(10):1222-1231. doi: 10.1634/theoncologist.2016-0414. Epub 2017 May 26.

19.

WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity.

Ferrand N, Béreziat V, Moldes M, Zaoui M, Larsen AK, Sabbah M.

Sci Rep. 2017 May 11;7(1):1749. doi: 10.1038/s41598-017-01866-2.

20.

A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group.

Bleiberg H, Decoster G, de Gramont A, Rougier P, Sobrero A, Benson A, Chibaudel B, Douillard JY, Eng C, Fuchs C, Fujii M, Labianca R, Larsen AK, Mitchell E, Schmoll HJ, Sprumont D, Zalcberg J.

Ann Oncol. 2017 May 1;28(5):922-930. doi: 10.1093/annonc/mdx050.

21.

How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials.

Bonnetain F, Borg C, Adams RR, Ajani JA, Benson A, Bleiberg H, Chibaudel B, Diaz-Rubio E, Douillard JY, Fuchs CS, Giantonio BJ, Goldberg R, Heinemann V, Koopman M, Labianca R, Larsen AK, Maughan T, Mitchell E, Peeters M, Punt CJA, Schmoll HJ, Tournigand C, de Gramont A.

Ann Oncol. 2017 Sep 1;28(9):2077-2085. doi: 10.1093/annonc/mdx191. Review.

PMID:
28430862
22.

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study.

Gerotziafas GT, Van Dreden P, Mathieu d'Argent E, Lefkou E, Grusse M, Comtet M, Sangare R, Ketatni H, Larsen AK, Elalamy I.

Thromb J. 2017 Mar 28;15:9. doi: 10.1186/s12959-017-0131-7. eCollection 2017.

23.

Cross Validation of HS-GC/MS to Quantify Total Carbon Dioxide in Horse Plasma.

Heffron B, Bash J, Larsen AK.

J Anal Toxicol. 2017 Apr 1;41(3):230-235. doi: 10.1093/jat/bkw133.

PMID:
28035033
24.

Antimicrobial Oligophenalenone Dimers from the Soil Fungus Talaromyces stipitatus.

Zang Y, Genta-Jouve G, Escargueil AE, Larsen AK, Guedon L, Nay B, Prado S.

J Nat Prod. 2016 Dec 23;79(12):2991-2996. doi: 10.1021/acs.jnatprod.6b00458. Epub 2016 Dec 14.

PMID:
27966935
25.

The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.

Sassi M, Chakroun T, Mbemba E, Van Dreden P, Elalamy I, Larsen AK, Gerotziafas GT.

Clin Appl Thromb Hemost. 2017 Mar;23(2):155-163. doi: 10.1177/1076029616665922. Epub 2016 Sep 24.

PMID:
27609342
26.

Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology.

Escargueil AE, Prado S, Dezaire A, Clairambault J, Larsen AK, Soares DG.

Curr Pharm Des. 2016;22(44):6625-6644. doi: 10.2174/1381612822666160831114002. Review.

PMID:
27587198
27.

Experimental Challenge of Atlantic Cod (Gadus morhua) with a Brucella pinnipedialis Strain from Hooded Seal (Cystophora cristata).

Nymo IH, Seppola M, Al Dahouk S, Bakkemo KR, Jiménez de Bagüés MP, Godfroid J, Larsen AK.

PLoS One. 2016 Jul 14;11(7):e0159272. doi: 10.1371/journal.pone.0159272. eCollection 2016.

28.

Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery.

Denis JA, Patroni A, Guillerm E, Pépin D, Benali-Furet N, Wechsler J, Manceau G, Bernard M, Coulet F, Larsen AK, Karoui M, Lacorte JM.

Mol Oncol. 2016 Oct;10(8):1221-31. doi: 10.1016/j.molonc.2016.05.009. Epub 2016 Jun 7.

29.

Dual inhibition of ATR and ATM potentiates the activity of trabectedin and lurbinectedin by perturbing the DNA damage response and homologous recombination repair.

Lima M, Bouzid H, Soares DG, Selle F, Morel C, Galmarini CM, Henriques JA, Larsen AK, Escargueil AE.

Oncotarget. 2016 May 3;7(18):25885-901. doi: 10.18632/oncotarget.8292.

30.

Brucella pinnipedialis in hooded seal (Cystophora cristata) primary epithelial cells.

Larsen AK, Godfroid J, Nymo IH.

Acta Vet Scand. 2016 Jan 25;58:9. doi: 10.1186/s13028-016-0188-5.

31.

PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer.

Chibaudel B, Maindrault-Gœbel F, Bachet JB, Louvet C, Khalil A, Dupuis O, Hammel P, Garcia ML, Bennamoun M, Brusquant D, Tournigand C, André T, Arbaud C, Larsen AK, Wang YW, Yeh CG, Bonnetain F, de Gramont A.

Cancer Med. 2016 Apr;5(4):676-83. doi: 10.1002/cam4.635. Epub 2016 Jan 24.

32.

Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status.

Huguet F, Fernet M, Giocanti N, Favaudon V, Larsen AK.

Target Oncol. 2016 Jun;11(3):371-81. doi: 10.1007/s11523-015-0403-8.

PMID:
26668065
33.

Unique features of trabectedin mechanism of action.

Larsen AK, Galmarini CM, D'Incalci M.

Cancer Chemother Pharmacol. 2016 Apr;77(4):663-71. doi: 10.1007/s00280-015-2918-1. Epub 2015 Dec 14. Review.

PMID:
26666647
34.

Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial.

Tournigand C, Chibaudel B, Samson B, Scheithauer W, Vernerey D, Mésange P, Lledo G, Viret F, Ramée JF, Tubiana-Mathieu N, Dauba J, Dupuis O, Rinaldi Y, Mabro M, Aucoin N, Latreille J, Bonnetain F, Louvet C, Larsen AK, André T, de Gramont A.

Lancet Oncol. 2015 Nov;16(15):1493-1505. doi: 10.1016/S1470-2045(15)00216-8. Epub 2015 Oct 22. Erratum in: Lancet Oncol. 2015 Dec;16(16):e589.

PMID:
26474518
35.

Organizing workplace health literacy to reduce musculoskeletal pain and consequences.

Larsen AK, Holtermann A, Mortensen OS, Punnett L, Rod MH, Jørgensen MB.

BMC Nurs. 2015 Sep 17;14:46. doi: 10.1186/s12912-015-0096-4. eCollection 2015.

36.

Unexpected talaroenamine derivatives and an undescribed polyester from the fungus Talaromyces stipitatus ATCC10500.

Zang Y, Genta-Jouve G, Sun TA, Li X, Didier B, Mann S, Mouray E, Larsen AK, Escargueil AE, Nay B, Prado S.

Phytochemistry. 2015 Nov;119:70-5. doi: 10.1016/j.phytochem.2015.09.002. Epub 2015 Sep 18.

PMID:
26386982
37.

Mixed exposure to bacterial lipopolysaccharide and seafood proteases augments inflammatory signalling in an airway epithelial cell model (A549).

Bhagwat SS, Larsen AK, Seternes OM, Bang BE.

Toxicol Ind Health. 2016 Nov;32(11):1866-1874. doi: 10.1177/0748233715590914. Epub 2016 Jul 9.

PMID:
26149191
38.

Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.

Ayadi M, Bouygues A, Ouaret D, Ferrand N, Chouaib S, Thiery JP, Muchardt C, Sabbah M, Larsen AK.

Oncotarget. 2015 Jul 30;6(21):18518-33.

39.

BRCA2 is needed for both repair and cell cycle arrest in mammalian cells exposed to S23906, an anticancer monofunctional DNA binder.

Rocca CJ, Soares DG, Bouzid H, Henriques JA, Larsen AK, Escargueil AE.

Cell Cycle. 2015;14(13):2080-90. doi: 10.1080/15384101.2015.1042632.

40.

Emergence of drug tolerance in cancer cell populations: an evolutionary outcome of selection, nongenetic instability, and stress-induced adaptation.

Chisholm RH, Lorenzi T, Lorz A, Larsen AK, de Almeida LN, Escargueil A, Clairambault J.

Cancer Res. 2015 Mar 15;75(6):930-9. doi: 10.1158/0008-5472.CAN-14-2103. Epub 2015 Jan 27.

41.

[Marjolin's ulcer in a 54-year-old skin graft].

Larsen AK, Nielsen AM.

Ugeskr Laeger. 2014 Dec 15;176(25A). pii: V12120744. Danish.

PMID:
25497631
43.

Polyethylenimine architecture-dependent metabolic imprints and perturbation of cellular redox homeostasis.

Hall A, Parhamifar L, Lange MK, Meyle KD, Sanderhoff M, Andersen H, Roursgaard M, Larsen AK, Jensen PB, Christensen C, Bartek J, Moghimi SM.

Biochim Biophys Acta. 2015 Mar;1847(3):328-342. doi: 10.1016/j.bbabio.2014.12.002. Epub 2014 Dec 5.

44.

Long-term Survival after Metastatic Childhood Melanoma.

Larsen AK, Jensen MB, Krag C.

Plast Reconstr Surg Glob Open. 2014 Jul 9;2(6):e163. doi: 10.1097/GOX.0000000000000122. eCollection 2014 Jun.

45.

Neglected giant scalp Basal cell carcinoma.

Larsen AK, El-Charnoubi WA, Gehl J, Krag C.

Plast Reconstr Surg Glob Open. 2014 Apr 7;2(3):e120. doi: 10.1097/GOX.0000000000000066. eCollection 2014 Mar.

46.

Isolated malignant melanoma metastasis to the pancreas.

Larsen AK, Krag C, Geertsen P, Jakobsen LP.

Plast Reconstr Surg Glob Open. 2013 Dec 6;1(8):e74. doi: 10.1097/GOX.0000000000000018. eCollection 2013 Nov.

48.

Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.

Akalay I, Tan TZ, Kumar P, Janji B, Mami-Chouaib F, Charpy C, Vielh P, Larsen AK, Thiery JP, Sabbah M, Chouaib S.

Oncogene. 2015 Apr 23;34(17):2261-71. doi: 10.1038/onc.2014.151. Epub 2014 Jun 16.

PMID:
24931170
49.

Adoption of workplaces and reach of employees for a multi-faceted intervention targeting low back pain among nurses' aides.

Rasmussen CD, Larsen AK, Holtermann A, Søgaard K, Jørgensen MB.

BMC Med Res Methodol. 2014 May 1;14:60. doi: 10.1186/1471-2288-14-60.

50.

Manifestations of Gorlin-Goltz syndrome.

Larsen AK, Mikkelsen DB, Hertz JM, Bygum A.

Dan Med J. 2014 May;61(5):A4829.

PMID:
24814739

Supplemental Content

Loading ...
Support Center